Dark

Check out our Level2View

AREVF
AREV LIFE SCIENCES GLOBAL
stock OTC

Inactive

Jan 27, 2025

0.0100USD0.000%(0.0000)23,333

Pre-market

Dec 31, 1969

0.00USD-100.000%(-0.01)0

After-hours

Dec 31, 1969

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 23, 2022

10:12AM EST AREV SAB member Richard Van Breeman PhD publishes landmark study on CoVid19 Benzinga

Dec 28, 2021

01:01PM EST AREV Life Sciences appoints Allan Echino as Director and Denby Greenslade as interim CFO Benzinga

Dec 14, 2021

01:31AM EST AREV Life Sciences Settles Pending Litigation with Harvey Benzinga

Dec 7, 2021

01:51AM EST AREV Life Sciences / Absolem JV Receives Extraction Results Benzinga

Dec 5, 2021

01:31AM EST AREV Acquires Wright & Well Essentials Inc. Benzinga

Nov 15, 2021

10:29AM EST AREV Life Sciences Global Corp Announces Stock Option Grant Benzinga

Sep 12, 2021

12:51PM EDT AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB REVISED RELEASE first issued July 28, 2021 Benzinga

Sep 7, 2021

07:41AM EDT AREV Announces Brian Cameron as Chief Financial Officer Benzinga

Aug 14, 2021

07:11AM EDT AREV Changes their name to AREV Life Sciences Global Corp. Benzinga

Aug 3, 2021

02:31AM EDT AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB Benzinga

Jul 27, 2021

05:04AM EDT Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN(TM), a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation Benzinga

Jul 25, 2021

03:01AM EDT AREV Annual and Special General Meeting Results Appoints Mel Maxwell as an AREV Director Benzinga

Jun 21, 2021

07:51AM EDT AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods Benzinga

Jun 16, 2021

07:51AM EDT AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock Benzinga

Jun 8, 2021

07:01AM EDT Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs Benzinga

Jun 7, 2021

07:51AM EDT AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board Benzinga

Jun 6, 2021

01:51PM EDT AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs Benzinga

01:11PM EDT AREV Nanotec Brands Inc. Announces Management Cease Trade Order Revoked Benzinga

May 19, 2021

11:51AM EDT AREV Nanotec Brands Inc. Provides Management Cease Trade Order Update Benzinga

Share